Periorbital erythema as a presenting sign of COVID-19
Samantha Kalner, Irene Vergilis
Abstract
Reports in literature of the presence of cutaneous findings in patients who have tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), which causes coronavirus disease 2019 (COVID-19), have ranged from 20.4%1 to 0.2% of cases.2 Reported cutaneous manifestations span from nonpruritic to pruritic erythematous morbilliform eruptions involving the trunk, to localized or widespread urticaria, to chickenpox-like vesicles.1 Petechial rash has also been described at the initial presentation of the COVID-19 disease,3 along with confluent erythematous-yellowish papules on heels bilaterally that presented 13 days after the onset of COVID-19 and which progressed to pruritic, hard, erythematous plaques.